Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome

Overview

Journal Front Pharmacol

Date 2022 Aug 12

PMID 35959444

Authors

Hongying Shan

Renxin Luo

Xuanying Guo

Rong Li

Zhenhong Ye

Tianliu Peng

Fenting Liu

Zi Yang

Affiliations

Soon will be listed here.

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder in women of childbearing age. Individual heterogeneity is evident, and the prevalence rate ranges between 6 and 15% globally. The prevalence rate of PCOS in Chinese women of childbearing age is 5.6%. The main manifestations are infertility, sparse menstruation, irregular vaginal bleeding, long-term endometrial hyperplasia, and endometrial cancer. PCOS is often associated with hyperandrogenemia, insulin resistance, hyperinsulinemia, obesity, metabolic syndrome, and intestinal flora disorder. Although there have been many studies in the past, the underlying pathophysiological mechanism of the disease is still unclear. Studies have shown that PCOS diseases and related complications are closely related to local oxidative stress imbalance in the endometrium, leading to poor endometrial receptivity and effects on pregnancy. Previous reviews have mainly focused on the abnormal mechanism of ovarian oxidative stress in women with PCOS, while reviews on endometrial receptivity and oxidative stress are relatively insufficient. This study reviews the abnormal cellular and molecular mechanisms of oxidative stress due to comorbidities in women with PCOS, leading to a downregulation of endometrial receptivity.

Citing Articles

The role of immunity in insulin resistance in patients with polycystic ovary syndrome.

Zhang Q, Yang Z, Ou X, Zhang M, Qin X, Wu G Front Endocrinol (Lausanne). 2025; 15:1464561.

PMID: 39911236 PMC: 11797073. DOI: 10.3389/fendo.2024.1464561.

Modulatory impact of subsp. BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection.

Dong Y, Yang S, Zhang S, Zhao Y, Li X, Han M mSphere. 2025; 10(2):e0088724.

PMID: 39898662 PMC: 11853005. DOI: 10.1128/msphere.00887-24.

Factors influencing endometrial receptivity in women with recurrent implantation failure.

Opuchlik K, Pankiewicz K, Pierzynski P, Sierdzinski J, Aleksejeva E, Salumets A BMC Womens Health. 2025; 25(1):15.

PMID: 39789542 PMC: 11715555. DOI: 10.1186/s12905-024-03531-z.

A risk prediction model for endometrial hyperplasia/endometrial carcinoma in premenopausal women.

Li Z, Yin J, Liu Y, Zeng F Sci Rep. 2025; 15(1):1019.

PMID: 39762365 PMC: 11704268. DOI: 10.1038/s41598-024-83568-0.

Ding N, Wang R, Wang P, Wang F Proteome Sci. 2024; 22(1):14.

PMID: 39702179 PMC: 11660692. DOI: 10.1186/s12953-024-00238-9.

References

Long X, Li R, Yang Y, Qiao J . Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome. Reprod Sci. 2016; 24(2):252-257. DOI: 10.1177/1933719116653681. View

Johnson R, Nakagawa T, Sanchez-Lozada L, Shafiu M, Sundaram S, Le M . Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013; 62(10):3307-15. PMC: 3781481. DOI: 10.2337/db12-1814. View

Bloch-Damti A, Bashan N . Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal. 2005; 7(11-12):1553-67. DOI: 10.1089/ars.2005.7.1553. View

Wollenhaupt K, Brussow K, Albrecht D, Tomek W . The Akt/mTor signaling cascade is modified during placentation in the porcine uterine tissue. Reprod Biol. 2013; 13(3):184-94. DOI: 10.1016/j.repbio.2013.06.001. View

Heard M, Melnyk S, Simmen F, Yang Y, Pabona J, Simmen R . High-Fat Diet Promotion of Endometriosis in an Immunocompetent Mouse Model is Associated With Altered Peripheral and Ectopic Lesion Redox and Inflammatory Status. Endocrinology. 2016; 157(7):2870-82. PMC: 4929556. DOI: 10.1210/en.2016-1092. View

Pei C, Jin L, Baek K . Pathogenetic analysis of polycystic ovary syndrome from the perspective of omics. Biomed Pharmacother. 2021; 142:112031. DOI: 10.1016/j.biopha.2021.112031. View

Mahdi H, Xiu J, Reddy S, DeBernardo R . Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma. J Surg Oncol. 2015; 112(2):188-94. DOI: 10.1002/jso.23993. View

Ashkenazi J, Farhi J, Orvieto R, Homburg R, Dekel A, Feldberg D . Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient. Fertil Steril. 1995; 64(3):564-7. DOI: 10.1016/s0015-0282(16)57793-0. View

Enli Y, Fenkci S, Fenkci V, Oztekin O . Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome. Gynecol Endocrinol. 2013; 29(12):1036-9. DOI: 10.3109/09513590.2013.829442. View

10.

Ur Rahman T, Ullah K, Guo M, Pan H, Liu J, Ren J . Androgen-induced alterations in endometrial proteins crucial in recurrent miscarriages. Oncotarget. 2018; 9(37):24627-24641. PMC: 5973874. DOI: 10.18632/oncotarget.24821. View

11.

Saklayen M . The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2):12. PMC: 5866840. DOI: 10.1007/s11906-018-0812-z. View

12.

Hu M, Zhang Y, Guo X, Jia W, Liu G, Zhang J . Perturbed ovarian and uterine glucocorticoid receptor signaling accompanies the balanced regulation of mitochondrial function and NFκB-mediated inflammation under conditions of hyperandrogenism and insulin resistance. Life Sci. 2019; 232:116681. DOI: 10.1016/j.lfs.2019.116681. View

13.

Lindheim L, Bashir M, Munzker J, Trummer C, Zachhuber V, Leber B . Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. PLoS One. 2017; 12(1):e0168390. PMC: 5207627. DOI: 10.1371/journal.pone.0168390. View

14.

Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker A . Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol. 2003; 101(6):1177-82. DOI: 10.1016/s0029-7844(03)00233-3. View

15.

Peng Z, Sun Y, Lv X, Zhang H, Liu C, Dai S . Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(2):e0148531. PMC: 4746122. DOI: 10.1371/journal.pone.0148531. View

16.

Sun L, Hu W, Liu Q, Hao Q, Sun B, Zhang Q . Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res. 2012; 11(5):2937-46. DOI: 10.1021/pr3000317. View

17.

Vahidnezhad H, Youssean L, Uitto J . Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities. J Invest Dermatol. 2016; 136(1):15-23. DOI: 10.1038/JID.2015.331. View

18.

Samy N, Hashim M, Sayed M, Said M . Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers. 2009; 26(4):163-70. PMC: 3833606. DOI: 10.3233/DMA-2009-0627. View

19.

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Futterweit W . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2008; 91(2):456-88. DOI: 10.1016/j.fertnstert.2008.06.035. View

20.

Li R, Wu J, He J, Wang Y, Liu X, Chen X . Mice endometrium receptivity in early pregnancy is impaired by maternal hyperinsulinemia. Mol Med Rep. 2017; 15(5):2503-2510. PMC: 5428841. DOI: 10.3892/mmr.2017.6322. View